Violaine S. Mitchell, Nalini M. Philipose, and Jay P. Sanford, Editors; Committee on the Children's Vaccine Initiative: Planning Alternative Strategies, Institute of Medicine

• 1 FRONT MATTER; 2 1 Executive Summary; 3 2 Why a Children's Vaccine Initiative; 4 3 Resources and Infrastructure; 5 4 Vaccine Demand and Supply; 6 5 Investing in New and Improved Vaccines; 7 6 Stages of Vaccine Development; 8 7 A Strategy to Enhance U.S. Participation in the Children's Vaccine Initiative; 9 Appendix A: Relevant Intellectual Property Rights Law; 10 Appendix B: National Vaccine Injury Compensation Program; 11 Appendix C: Regulatory Aspects of Vaccine Development, Manufacture, and Distribution; 12 Appendix D: Strategies for Achieving Full U.S. Participation in the Children's Vaccine Initiative; 13 Appendix E: Public Health Service Act (1944); 14 Appendix F: National Vaccine Program Legislation; 15 Appendix G: Immunization Schedules; 16 Appendix H: Historical Record of Vaccine Product License Holders in the United States; 17 Appendix I: Working Group Participants; 18 Appendix J: Committee and Staff Biographies; 19 Appendix K: Acronyms

Select Guide Rating